BNB Plus Corp. (BNBX)
US — Healthcare Sector
Automate Your Wheel Strategy on BNBX
With Tiblio's Option Bot, you can configure your own wheel strategy including BNBX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BNBX
- Rev/Share 5.7647
- Book/Share 12.2165
- PB 0.245
- Debt/Equity 0.046
- CurrentRatio 2.7647
- ROIC -1.6265
- MktCap 4016136.0
- FreeCF/Share -23.1825
- PFCF -0.3029
- PE -0.1349
- Debt/Assets 0.0337
- DivYield 0
- ROE -1.3313
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About BNB Plus Corp. (BNBX)
- IPO Date 2025-10-08
- Website https://www.bnbx.io
- Industry Biotechnology
- CEO Clay D. Shorrock
- Employees 46
BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.